Andrew Dunn (@andrewedunn.bsky.social)

FDA head Makary’s short-lived CRL ask on KalVista’s drug raises more concerns of political intervention FDA Commissioner Marty Makary’s unsuccessful attempt to intervene in an ongoing drug review, as described by multiple agency sources, raises further concerns about the regulator under its new leadersh... https://endpoints.news/fda-head-makarys-intervention-attempt-on-kalvista-raises-concerns/